Laboratory reporting systems in the European Union—sentinel (sample based) laboratory reporting systems
Year introduced | STIs | Sample | Variables reported | Reporting frequency | Negative results reported | Coverage | |
---|---|---|---|---|---|---|---|
Ct, Chlamydia trachomatis; Gc, gonorrhoea; Gc AMR, gonococcal antimicrobial resistance; H, genital herpes; NSC, National Surveillance Centre; Syph, syphilis; NA, not applicable: system not in operation in that country. A, age; C, clinic type; D, date of diagnosis; G, gender; I, country where infection contracted; L, type of laboratory test used; N, number of positive results only, by region; P, place of diagnosis; S, specimen type/site of infection. | |||||||
Belgium | 1986 | Gc, Ct | 129 laboratories (public and private) | Individual A, G, L, S | Daily or weekly | No | About half the laboratories in Belgium take part in the sentinel system |
France RENAGO RENACHLA | 1986 | Gc, Ct, GC AMR | Public and private labs geographically representative sample | Individual A, C, D, G, I, L, P, S | Monthly | Yes (aggregate: total number tests performed each month) | 5% of all labs; 10–25% of G & C cases in country |
Netherlands ISIS | 1999 | Syphilis, Gc, Ct | Convenience sample of labs, ongoing progressive recruitment | Individual A, C, D, G, L, P, S | Daily to RIVM (automatic electronic upload overnight) | Yes | Covers about 3/16 million population |
Spain SIM | 1989 | Syphilis, Gc, Ct, Herpes | 44 laboratories | Aggregate: no. positive diagnoses by sex | Time delay to ISCIII ∼1 month | No | Covers ∼25% of population |